Market Overview:

The global blood collection market size reached US$ 6.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.94% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Blood collection involves the voluntary removal of blood from the body for laboratory analysis. It is usually collected within a hospital environment to identify metabolic, respiratory, and mixed-acid disorders. Some of the popular methods of blood collection are arterial, venipuncture and fingerstick sampling. Blood collection plays a crucial role in understanding, preventing and treating disease across hospitals and blood bank centers. The blood is extracted through automated equipment or manually and then separated into various components using the apheresis process. The blood samples can also be taken from the arm, ear, hand, and other parts of the body, depending on the requirement.

Blood Collection Market Trends:

The global blood collection market is primarily driven by the increasing number of surgical procedures performed in hospitals. Blood collection products are used in the treatment of patients undergoing chemotherapy, dialysis, organ and tissue transplantation, and complex surgeries. The growing cases of chronic and lifestyle diseases on account of sedentary lifestyles have also necessitated greater adherence to regular health checkups. This has escalated the need for blood collection as the primary mode of diagnosing diseases. Besides this, governments of several countries are taking initiatives to increase the number of blood donations and create awareness about its importance amidst the outbreak of coronavirus disease (COVID-19). Such programs are driving the blood collection market globally during the pandemic. Furthermore, technological advancements in the field of blood collection are facilitating the market growth. For instance, market players have introduced a push-button blood collection device, which can be used for testing HbA1c levels in diabetic and prediabetic patients. Other factors, including the rising cases of accidents and the adoption of preventive care and diagnostics among individuals, are further expected to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood collection market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end use.

Breakup by Product:

• Needles and Syringes
• Blood Collection Tubes
  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
• Blood Bags
• Others
   

Breakup by Application:

• Diagnostics
• Treatment
   

Breakup by End Use:

• Hospitals
• Diagnostics Centers
• Blood Banks
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, FL MEDICAL s.r.l., Greiner AG, Haemonetics Corporation, McKesson Corporation, Medtronic plc, Nipro Corporation, Qiagen N.V., Quest Diagnostics, Sarstedt AG & Co. KG and Terumo Corporation.

Report Coverage: